IP Library Assignment 051824/0913
Patent Assignment
Reel/Frame 051824/0913

Assignment of Assignor's Interest

Recorded: 2020-02-14 Pages: 20
Assignor
OSIRIS THERAPEUTICS, INC.
Executed: 2013-10-10
Assignee
MESOBLAST INTERNATIONAL SARL
ROUTE DE PRE-BOIS 20, MEYRIN, 1217, SWITZERLAND
Covered Properties (3)
Mesenchymal Stem Cells and Uses Therefor
Application: 16/204,936 →
Publication: US 2019/0175657
Mesenchymal Stem Cells and Uses Therefor
Application: 16/206,235 →
Publication: US 2019/0201447
Mesenchymal Stem Cells and Uses Therefor
Application: 16/214,485 →
Publication: US 2019/0240259
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 14, 2020
From: AGGARWAL, SUDEEPTA; PITTENGER, MARK F.; VARNEY, TIMOTHY
To: OSIRIS THERAPEUTICS, INC.
Reel/Frame 051824/0376 →
Security Interest Dec 10, 2021
From: MESOBLAST LIMITED ACN 109 431 870; MESOBLAST UK LIMITED; MESOBLAST, INC. (FORMERLY KNOWN AS ANGIOBLAST, INC.); MESOBLAST INTERNATIONAL SÀRL
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 058957/0447 →
Release of Security Interest in Intellectual Property Jan 2, 2026
From: OAKTREE FUND ADMINISTRATION, LLC, AS AGENT
To: MESOBLAST LIMITED; MESOBLAST UK LIMITED; MESOBLAST, INC. (FORMERLY KNOWN AS ANGIOBLAST, INC.); MESOBLAST INTERNATIONAL SÀRL
Reel/Frame 074174/0183 →